Table 2. Readmissions for heart failure and mortality at three months and at one year.

Patients	Total	Sacubitril-valsartán	ACEI	P
Data are presented as n (%). ACEI: angiotensin converting enzyme inhibitor; HF: heart failure.
At three months	n = 183	n = 101	n = 82
Readmission for HF	12 (6.6%)	6 (5.9%)	6 (7.3%)	NS
Readmission for HF or death	17 (9.3%)	7 (6.9%)	10 (12.2%)	NS
At one year	n = 144	n = 71	n = 73
Readmission for HF	21 (14.6%)	9 (12.7%)	12 (16.4%)	NS
Readmission for HF or death	36 (25%)	16 (22.5%)	20 (27.4%)	NS